Trial Profile
A Two-Part, Randomized, Placebo-Controlled, Crossover Trial to Evaluate the Differential Effects of Inhaled Nedocromil, Oral Montelukast, and Inhaled Mometasone on Markers of the Early Airway Response to Allergen in Asthmatics
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Mometasone (Primary) ; Montelukast (Primary) ; Nedocromil (Primary)
- Indications Asthma
- Focus Biomarker; Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 25 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2011 Planned End Date changed from 1 Feb 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.
- 13 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.